Health Tech Suppliers Share Insights for 2026
Health tech suppliers predict significant advancements in NHS technology by 2026, focusing on AI integration, patient-centered care, and improved data management. π₯π»
January 2, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 𧬠Rare Diseases.
MRI quantitative imaging biomarkers in differentiating brain parenchymal tuberculoma and lung cancer brain metastases.
MRI radiomics model distinguishes brain tuberculoma from lung cancer metastases with AUC up to 0.986. ππ§
December 17, 2025
Quantitative Imaging for Interstitial Lung Disease.
Quantitative imaging enhances ILD diagnosis and treatment, utilizing CT and emerging MRI techniques. ππ«
December 5, 2025
Artificial Intelligence and Radiogenomics for Pediatric CNS Neoplasms.
AI & Radiogenomics in Pediatric CNS Tumors: 2021 WHO guidelines enhance diagnosis via molecular profiling. Promising future ahead! π§ β¨
November 23, 2025
Rare disease education in medical schools: patient-centered and innovative strategies.
Rare diseases affect 300 million globally. Medical education must adapt to improve care. ππ
November 22, 2025
Cracking the code: a head-to-head comparison of expert clinicians and artificial intelligence in diagnosing rare diseases.
AI vs. Clinicians: 28% Diagnosis Match in Rare Diseases π€π©Ί
November 7, 2025
New avenues in childhood vasculitis.
Exploring childhood vasculitis: recent advances in diagnosis, treatment, and future directions. ππ©Ί
October 8, 2025
New Wearable Device Aims to Monitor Muscle Health in Older Adults
New wearable device monitors muscle health in older adults. π¦΅π Aims to detect sarcopenia for timely intervention.
September 29, 2025
Lung lobe segmentation: performance of open-source MOOSE, TotalSegmentator, and LungMask models compared to a local in-house model.
Lung lobe segmentation tools evaluated: TotalSegmentator excels, while data diversity enhances model accuracy. ππ«
September 5, 2025
Global research landscape of retinoblastoma biomarkers: a multidisciplinary bibliometric analysis based on multiple databases (2005-2025).
π Retinoblastoma biomarkers research shows steady growth, with China leading publications. Key hotspots include liquid biopsy and AI integration. π¬
August 16, 2025